D
Obsidian Therapeutics, Inc. OBX
$18.68 -$0.05-0.27% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2026 06/30/2025
Total Cash And Short-Term Investments -41.38% --
Total Receivables -- --
Inventory -- --
Prepaid Expenses 159.90% --
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets -- --
Total Current Assets -27.61% --

Total Current Assets -27.61% --
Net Property, Plant & Equipment -19.89% --
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles -- --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets 0.00% --
Total Assets -26.65% --

Total Accounts Payable -50.54% --
Total Accrued Expenses 50.74% --
Short-term Debt -- --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current -21.82% --
Total Finance Division Other Current Liabilities 39.61% --
Total Other Current Liabilities 39.61% --
Total Current Liabilities 32.62% --

Total Current Liabilities 32.62% --
Long-Term Debt -- --
Short-term Debt -- --
Capital Leases -13.59% --
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities -66.67% --
Total Liabilities 29.56% --

Common Stock & APIC 5.96% --
Retained Earnings -8.20% --
Treasury Stock & Other 40.00% --
Total Common Equity -8.51% --

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible 0.00% --
Preferred Stock, Others -- --
Total Preferred Equity 0.00% --

Total Common Equity -8.51% --
Total Preferred Equity 0.00% --
Total Minority Interest -- --
Total Equity -43.68% --